| Autor: |
Bobeva, Y., Castro-Gomez, S., Kittipeerapat, N., Heneka, M., Weydt, P., Gaur, N., Wang, M., Steinbach, R., Riemenschneider, H., Edbauer, D., Plaas, M., Witte, O., Brill, M., Großkreutz, J., Monteiro Lopes, D., A. Conceição, V., Lopes, C. S., Gromicho, M., Santos, N. C., . Carvalho, F. A |
| Předmět: |
|
| Zdroj: |
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration; Nov2022 Suppl 1, Vol. 23 Issue 1, p99-109, 11p |
| Abstrakt: |
Higher blood high density lipoprotein and apolipoprotein A1 levels are associated with reduced risk of developing amyotrophic lateral sclerosis. Title is CSF chemokine alterations related to the clinical course of amyotrophic lateral sclerosis. Blood biomarkers of carbohydrate, lipid, and apolipoprotein metabolisms and risk of amyotrophic lateral sclerosis: a more than 20-year follow-up of the Swedish AMORIS cohort. [Extracted from the article] |
| Databáze: |
Complementary Index |
| Externí odkaz: |
|
|
Nepřihlášeným uživatelům se plný text nezobrazuje |
K zobrazení výsledku je třeba se přihlásit.
|
